InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the full record of transactions filed by Bonello William, Chairman & CEO. Director active across 1 company, notably Neogenomics INC. In total, 10 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €54k. History available since 24 November 2021. The latest transaction was disclosed on 28 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
5,727 shares@ US$7.520.0038% mcap5.2% of flowCommon StockSEC:0001077183-22-000071:0
82,305 shares0Common StockSEC:0001077183-22-000056:0
3,209 shares@ US$18.290.0050% mcap6.9% of flowCommon StockSEC:0001077183-22-000049:0
40,869 shares0Common StockSEC:0001077183-22-000040:0
21,400 shares0Common StockSEC:0001077183-21-000275
21,400 shares0Common StockSEC:0001077183-21-000275:0
25,000 shares@ US$7.520.016% mcap21.2% of flowCommon StockSEC:0001077183-21-000254:0
25,000 shares@ US$7.520.016% mcap48.3% of flowCommon StockSEC:0001077183-21-000254
25,000 shares@ US$8.030.017% mcap22.7% of flowCommon StockSEC:0001077183-21-000251:0
25,000 shares@ US$8.030.017% mcap51.7% of flowCommon StockSEC:0001077183-21-000251
10 of 10 declarations
About Bonello William
William Bonello is the President, Informatics, and Chief Financial Officer at Neogenomics Inc. He oversees the financial operations and IT strategies of the company. Neogenomics specializes in genetic diagnostic services. William's experience in both finance and technology is essential for the company's innovation and growth.
